Communiqués Photocure ASA

Actions

PHO

NO0010000045

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
59,1 ^NOK	-1,99%		-3,90%	-12,31%

04/06	Photocure ASA annonce une initiative de tour BLC mobile pour élargir l'accès à Cysview aux États-Unis	CI
23/05	Photocure ASA annonce des nominations au conseil d'administration	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.	04/06	AQ
Photocure ASA - Annual general meeting held	23/05	AQ
Photocure ASA, Results for the first quarter of 2024	16/05	AQ
Photocure ASA: Results for the first quarter of 2024	15/05	AQ
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China	12/05	AQ
Photocure ASA: Invitation to presentation of first quarter 2024 financial results	08/05	AQ
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024	07/05	AQ
Photocure ASA - Notice of the Annual General Meeting 23 May 2024	30/04	AQ
Photocure ASA: Annual Report 2023	30/04	AQ
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy	30/04	AQ
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy	30/04	AQ
Photocure ASA - Share option grant	25/04	AQ
Photocure ASA - European Association of Urology 2024 congress features new data on modern technology use in bladder cancer care	09/04	AQ
Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference	08/04	AQ
European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care	08/04	AQ
Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference	05/04	AQ
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy	28/03	AQ
Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting	18/03	AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO	23/02	AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO	23/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Photocure ASA

Actions

PHO

NO0010000045

Communiqués

Filtres